Christina (Tina) P: Help Advance Research and Support Patients with Antiphospholipid Syndrome
Christina (Tina) P., CEO and Co-Founder of APS Foundation of America, shared on LinkedIn:
”Antiphospholipid Syndrome (APS) is an autoimmune disorder where your immune system mistakenly attacks proteins in your blood, making it clot more easily.
This can lead to serious health problems like blood clots in veins and arteries (deep vein thrombosis, pulmonary embolism), strokes, heart attacks, and repeated miscarriages or stillbirths.
It can affect anyone, though it’s more common in women and often diagnosed between ages 20 and 40.
Here’s why donating to the APS Foundation of America, Inc. is so important:
The APS Foundation of America is dedicated to supporting both adult and pediatric research into APS. In 2025, they awarded three $10,000 microgrants to research teams and $10,000 to ICAPA. They also aim to set aside 10% of donations for future research funding.
Education and Awareness: They provide vital information and education about APS to patients, their families, and the general community.
This includes information on diagnosis, symptoms, treatment, and coping.
They also work to raise national awareness for APS, which is the leading cause of stroke in young people and a significant factor in recurrent miscarriages.
The APS Foundation of America offers support and resources for those living with APS, including a network of doctors familiar with the condition and an online forum for communication with other patients.
They advocate for earlier diagnosis and better patient care.
Founded in 2005, the APS Foundation of America is a volunteer-run 501(c)(3) public charity.
They strive to keep administrative costs low, with many members being patients themselves.
They also aim for transparency, with a Charity Navigator score of 98% for accountability and finance.
Your donations help the APS Foundation of America continue its crucial work in fighting this often-misunderstood illness, advancing research, and supporting those affected.
Corporate Donations message us.”
Stay updated with Hemostasis Today.
-
Sep 17, 2026, 09:14Angela Weyand: ASH 2026 Iron Deficiency Guidelines
-
Sep 17, 2026, 08:18Anirban Sen Gupta: From Flow to Clot Insights Into Hemostasis and Thrombosis
-
Sep 17, 2026, 08:03Aya Sherif: HEMO COP – Building a Collaborative Future for Hemophilia Care
-
Sep 17, 2026, 07:50Applications Are Now Open for the 2026 WFH IHTC Fellowships
-
Sep 17, 2026, 07:37Jim Hoffman: Could NET Removal Help Restore Vascular Homeostasis?
-
Sep 17, 2026, 04:43Tom Tang: Preventing Post Thrombotic Syndrome Starts With Early DVT Prevention
-
Sep 17, 2026, 04:35Veronica Sanchez: Menopause as a Risk for Heart Disaese
-
Sep 17, 2026, 03:20Jessica Frye: Understanding VTE in Pregnancy and the Postpartum Period
-
Sep 17, 2026, 03:04Leonardo Roever: Exploring the Role of Glutamine Metabolism in Atherosclerosis